These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9122239)

  • 1. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.
    Ilan Y; Droguett G; Chowdhury NR; Li Y; Sengupta K; Thummala NR; Davidson A; Chowdhury JR; Horwitz MS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2587-92. PubMed ID: 9122239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses.
    Ilan Y; Sauter B; Chowdhury NR; Reddy BV; Thummala NR; Droguett G; Davidson A; Ott M; Horwitz MS; Chowdhury JR
    Hepatology; 1998 May; 27(5):1368-76. PubMed ID: 9581693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat.
    Ilan Y; Jona VK; Sengupta K; Davidson A; Horwitz MS; Roy-Chowdhury N; Roy-Chowdhury J
    Hepatology; 1997 Oct; 26(4):949-56. PubMed ID: 9328318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.
    Ilan Y; Attavar P; Takahashi M; Davidson A; Horwitz MS; Guida J; Chowdhury NR; Chowdhury JR
    J Clin Invest; 1996 Dec; 98(11):2640-7. PubMed ID: 8958229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats.
    Sauter BV; Parashar B; Chowdhury NR; Kadakol A; Ilan Y; Singh H; Milano J; Strayer DS; Chowdhury JR
    Gastroenterology; 2000 Nov; 119(5):1348-57. PubMed ID: 11054394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
    Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR
    J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
    Askari FK; Hitomi Y; Mao M; Wilson JM
    Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period.
    Takahashi M; Ilan Y; Chowdhury NR; Guida J; Horwitz M; Chowdhury JR
    J Biol Chem; 1996 Oct; 271(43):26536-42. PubMed ID: 8900123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
    Jia Z; Dankó I
    Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector.
    Toietta G; Mane VP; Norona WS; Finegold MJ; Ng P; McDonagh AF; Beaudet AL; Lee B
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3930-5. PubMed ID: 15753292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle.
    Pastore N; Nusco E; Vaníkova J; Sepe RM; Vetrini F; McDonagh A; Auricchio A; Vitek L; Brunetti-Pierri N
    Hum Gene Ther; 2012 Oct; 23(10):1082-9. PubMed ID: 22765254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo.
    Tada K; Chowdhury NR; Neufeld D; Bosma PJ; Heard M; Prasad VR; Chowdhury JR
    Liver Transpl Surg; 1998 Jan; 4(1):78-88. PubMed ID: 9457971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transfer.
    Wen S; Driscoll RM; Schneider DB; Dichek DA
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1777-82. PubMed ID: 11701465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat.
    Dankó I; Jia Z; Zhang G
    Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats.
    Schmitt F; Remy S; Dariel A; Flageul M; Pichard V; Boni S; Usal C; Myara A; Laplanche S; Anegon I; Labrune P; Podevin G; Ferry N; Nguyen TH
    Gastroenterology; 2010 Sep; 139(3):999-1007, 1007.e1-2. PubMed ID: 20546738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes.
    Tada K; Roy-Chowdhury N; Prasad V; Kim BH; Manchikalapudi P; Fox IJ; van Duijvendijk P; Bosma PJ; Roy-Chowdhury J
    Cell Transplant; 1998; 7(6):607-16. PubMed ID: 9853589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors.
    Dimmock D; Brunetti-Pierri N; Palmer DJ; Beaudet AL; Ng P
    Hum Gene Ther; 2011 Apr; 22(4):483-8. PubMed ID: 20973621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.